Eisai's Neuroscience Product Creation Unit and University College London partnered to research neurodegenerative diseases and proteostasis biomarkers

Eisai Co. Ltd.

Japan / Mid-Cap Biopharma ($1-$50 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

University College London

U.K. / Academic

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced